Disclaimer

The trademark information displayed on this page is public information and is provided for informational purposes only. This information may be incomplete, inaccurate, or outdated, and IndiaFilings does not guarantee its accuracy. IndiaFilings is an independent platform and is not associated, affiliated, or connected with any trademark listed in this database. We do not represent or speak on behalf of any such trademark. If you are trying to contact a specific trademark, please use their official channels. IndiaFilings cannot assist with queries directed at other companies.

TOFINIB-5

Class 5Status: Accepted
Application Number5918197
Trademark Status
Accepted
Trademark Class5
Application Date2023-05-01
Proprietor NameACCURIS NEURO PHARMACEUTICALS PVT. LTD.
Appropriate OfficeAHMEDABAD
StateRAJASTHAN
Trademark TypeWORD
User Details26/04/2023
Agent NameRAJEEV JAIN[2233]
Agent Address17, BHARAT MATA PATH, JAMNA LAL BAJAJ MARG, C-SCHEME, JAIPUR - 302 001- RAJASTHAN
Goods And Services Details[CLASS : 5] PHARMACEUTICAL AND MEDICAL PREPARATIONS WHICH ARE INCLUDED IN CLASS 5

Identical Trademarks

Similar trademarks found for this brand

1 found
BrandClassStatus
TOFINIB-55Accepted
Showing up to 6 identical trademarksView more on LEDGERS→

Trademark Protection

Automate the monitoring of your trademark application and filing of response to Government Objection or Hearing.

₹9,899+ GST

What's included:

✓
Brand Guard ( 1 application 1 class)
✓
Appointment of Lawyer
✓
Objection
✓
Hearing
✓
Infringement support (1)
✓
Power of Attorney (POA)

Frequently asked questions

Common questions about TOFINIB-5.

What is the status of trademark application 5918197?
The current status of trademark application 5918197 for TOFINIB-5 is Accepted.
What is the trademark class of TOFINIB-5?
TOFINIB-5 is registered under trademark class 5.
Who is the proprietor of TOFINIB-5?
The proprietor of TOFINIB-5 is ACCURIS NEURO PHARMACEUTICALS PVT. LTD..
When was trademark application 5918197 filed?
Trademark application 5918197 for TOFINIB-5 was filed on 2023-05-01.